Consumer Health Cancer / Immunology

MediLink and BioNTech Partner for Advanced Anti-Cancer Drug

Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...

 October 13, 2023 | News

CanariaBio and Hikma Sign Oregovomab Distribution and License Deal for MENA Region

"We are thrilled to partner with Hikma, a company with a strong presence in the MENA region and a proven track record of successful collaborations," said&n...

 October 11, 2023 | News

Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments

Thermo Fisher Scientific, the world leader in serving science,  expanded its manufacturing capacity in St. Louis to support biologic therapies for dis...

 October 06, 2023 | News

RevitaLash® Launches Global Initiative to Fight Breast Cancer

RevitaLash® Cosmetics is proud to announce the company's annual Pink mission to make an impact in the fight against breast cancer. This initiative...

 October 04, 2023 | News

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

  COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

 October 04, 2023 | News

FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

 October 04, 2023 | News

Akeso and RemeGen Team Up for Gastric Cancer Therapy Study

On September 28, 2023, Akeso (9926.HK) announced that its subsidiary, Akeso Pharma, will collaborate with RemeGen (Yantai) Co., Ltd. (688331.SH/0...

 October 02, 2023 | News

Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor

The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...

 September 29, 2023 | News

Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors

An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...

 September 29, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

 September 28, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

 September 26, 2023 | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...

 September 25, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

 September 21, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

 September 18, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close